NEW YORK, Oct. 2, 2020 /PRNewswire/ -- Rowley Law PLLC is
investigating potential securities law violations by AMAG
Pharmaceuticals, Inc. (NASDAQ: AMAG) and its board of directors
concerning the proposed acquisition of the company by Covis Group
S.à.r.l. Stockholders will receive $13.75 for each share of AMAG Pharmaceuticals
stock that they hold. The transaction is valued at approximately
$647 million and is expected to close
in November 2020.
If you are a stockholder of AMAG Pharmaceuticals, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/amag/. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-amag-pharmaceuticals-inc-301144970.html
SOURCE Rowley Law PLLC